BioLine RX (Israel) Overlap Studies Double Exponential Moving Average

BLRX Stock  ILS 8.10  0.10  1.25%   
BioLine RX overlap studies tool provides the execution environment for running the Double Exponential Moving Average study and other technical functions against BioLine RX. BioLine RX value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Double Exponential Moving Average study function is designed to identify and follow existing trends. BioLine RX overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was twenty-six with a total number of output elements of thirty-five. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to BioLine RX changes than the simple moving average.

BioLine RX Technical Analysis Modules

Most technical analysis of BioLine RX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioLine from various momentum indicators to cycle indicators. When you analyze BioLine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About BioLine RX Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioLine RX. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioLine RX based on widely used predictive technical indicators. In general, we focus on analyzing BioLine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioLine RX's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BioLine RX's intrinsic value. In addition to deriving basic predictive indicators for BioLine RX, we also check how macroeconomic factors affect BioLine RX price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Hype
Prediction
LowEstimatedHigh
1.988.1014.22
Details
Intrinsic
Valuation
LowRealHigh
1.667.7813.90
Details
Naive
Forecast
LowNextHigh
0.977.0913.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.5411.2715.00
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in BioLine Stock

BioLine RX financial ratios help investors to determine whether BioLine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLine with respect to the benefits of owning BioLine RX security.